Cardiac Drugs in Pregnancy

In the western world, the risk of cardiovascular disease in pregnancy has grown due to the increasing age at the first pregnancy and the worldwide obesity epidemic leading to early diabetes and hypertension. As a result more women are requiring drug therapy during pregnancy  and some data has shown...

Full description

Corporate Author: SpringerLink (Online service)
Other Authors: Sliwa, Karen. (Editor, http://id.loc.gov/vocabulary/relators/edt), Anthony, John. (Editor, http://id.loc.gov/vocabulary/relators/edt)
Language:English
Published: London : Springer London : Imprint: Springer, 2014.
Edition:1st ed. 2014.
Series:Current Cardiovascular Therapy
Subjects:
Online Access:https://doi.org/10.1007/978-1-4471-5472-3
LEADER 03308nam a22005415i 4500
001 978-1-4471-5472-3
003 DE-He213
005 20210617051001.0
007 cr nn 008mamaa
008 131121s2014 xxk| s |||| 0|eng d
020 |a 9781447154723  |9 978-1-4471-5472-3 
024 7 |a 10.1007/978-1-4471-5472-3  |2 doi 
050 4 |a RC681-688.2 
072 7 |a MJD  |2 bicssc 
072 7 |a MED010000  |2 bisacsh 
072 7 |a MJD  |2 thema 
082 0 4 |a 616.12  |2 23 
245 1 0 |a Cardiac Drugs in Pregnancy  |h [electronic resource] /  |c edited by Karen Sliwa, John Anthony. 
250 |a 1st ed. 2014. 
264 1 |a London :  |b Springer London :  |b Imprint: Springer,  |c 2014. 
300 |a XII, 131 p. 3 illus., 2 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Current Cardiovascular Therapy 
505 0 |a Introduction -- General principles and guidelines -- Management of Hypertension -- Management of Heart Failure -- Management of  coronary artery disease & Arrhythmia -- Anticoagulation in Pregnancy -- Obstetric drugs in management if Cardiovascular disease -- Pregnancy anaesthesia in patients with cardiovascular disease. 
520 |a In the western world, the risk of cardiovascular disease in pregnancy has grown due to the increasing age at the first pregnancy and the worldwide obesity epidemic leading to early diabetes and hypertension. As a result more women are requiring drug therapy during pregnancy  and some data has shown an altered pharmacodynamic profile in pregnant women when compared to the non-pregnant population. Cardiac Drugs in Pregnancy presents up-to-date research for the treatment of cardiovascular disease during pregnancy, and  discusses the most important indications of drug usage in pregnancy and postpartum. The book aims to assess the potential risk of drugs and their possible benefit against each other, making it an essential read for a wide range of health professionals involved in cardiac drug therapy in pregnancy. 
650 0 |a Cardiology. 
650 0 |a Obstetrics. 
650 0 |a Maternal and child health services. 
650 0 |a Pharmacotherapy. 
650 1 4 |a Cardiology.  |0 https://scigraph.springernature.com/ontologies/product-market-codes/H33037 
650 2 4 |a Obstetrics/Perinatology/Midwifery.  |0 https://scigraph.springernature.com/ontologies/product-market-codes/H26014 
650 2 4 |a Maternal and Child Health.  |0 https://scigraph.springernature.com/ontologies/product-market-codes/H27025 
650 2 4 |a Pharmacotherapy.  |0 https://scigraph.springernature.com/ontologies/product-market-codes/H69000 
700 1 |a Sliwa, Karen.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Anthony, John.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9781447154730 
776 0 8 |i Printed edition:  |z 9781447154716 
830 0 |a Current Cardiovascular Therapy 
856 4 0 |u https://doi.org/10.1007/978-1-4471-5472-3 
912 |a ZDB-2-SME 
912 |a ZDB-2-SXM 
950 |a Medicine (SpringerNature-11650) 
950 |a Medicine (R0) (SpringerNature-43714)